日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

eNOS Uncoupling-ER Stress-Mitochondrial Dysfunction Axis in the Development of Pulmonary Hypertension.

eNOS解偶联-内质网应激-线粒体功能障碍轴在肺动脉高压发展中的作用。

Murugesan Priya, Zhang Yunxia, Zhang Meng, Zhang Yixuan, Cai Hua

Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides.

利用网蛋白-1衍生、修饰和改进的小肽治疗肺动脉高压的新型和优越疗法

Murugesan Priya, Zhang Yuhan, Zhang Yixuan, Youn Ji Youn, Cai Hua

Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR

在类人模型中逆转肺动脉高压:内皮二氢叶酸还原酶的治疗靶向治疗

Murugesan, Priya; Zhang, Yixuan; Huang, Yuanli; Chenggong Zong, Nobel; Youn, Ji Youn; Chen, Wenhui; Wang, Chen; Loscalzo, Joseph; Cai, Hua

Targeting MicroRNA-192-5p, a Downstream Effector of NOXs (NADPH Oxidases), Reverses Endothelial DHFR (Dihydrofolate Reductase) Deficiency to Attenuate Abdominal Aortic Aneurysm Formation

靶向NOX(NADPH氧化酶)下游效应因子microRNA-192-5p,可逆转内皮细胞DHFR(二氢叶酸还原酶)缺乏,从而减轻腹主动脉瘤的形成。

Huang, Kai; Narumi, Taro; Zhang, Yixuan; Li, Qiang; Murugesan, Priya; Wu, Yusi; Liu, Norika Mengchia; Cai, Hua

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets

NADPH氧化酶和氧化酶串扰在心血管疾病中的作用:新的治疗靶点

Zhang, Yixuan; Murugesan, Priya; Huang, Kai; Cai, Hua